KOL Perspectives: Perceptions of Lupus Pipeline Therapy Data Presented at EULAR 2018
Summary
This KOL Insight briefing focuses on KOLs views of Pipeline Therapy Data Presented at EULAR 2018.
Questions topics -
- Opinion on abatacept failing to achieve its primary endpoint in its Phase III LN trial
- Views on the Phase III safety data for abatacept in LN
- Expectations regarding abatacept’s future development in lupus
- Opinion on ustekinumab’s ability to achieve partial improvements using SL
Read More
- Table of Contents
- Executive Summary
- Background
- Research Panel Composition
- Results & Implications
- Appendix
Read More